The cost of pulmonary thromboembolism treatment


Bugra Coskuner M., ÖZTUNA F. , BÜLBÜL Y. , Ozsu S.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.68, no.3, pp.293-304, 2020 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 68 Issue: 3
  • Publication Date: 2020
  • Doi Number: 10.5578/tt.70104
  • Title of Journal : TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
  • Page Numbers: pp.293-304

Abstract

Introduction: Primary aim of this study is to determine the financial burden of Vitamin K Antagonists (VKA), low molecular weight heparins (LMWH) and new oral anticoagulants (NOAC) which are used in the treatment of the pulmonary thromboembolism (PTE). Secondary aim is to show long term complications of the treatment options.